National and international developments in cancer, health and policy. Produced in collaboration with the Press Association unless otherwise stated.
A prostate cancer drug won’t be offered on the NHS any earlier in the treatment plans of patients living with the disease in England.
A combination of immunotherapy drugs will be made available to NHS patients with advanced and aggressive kidney cancer on the NHS in England.
A new drug combo has been made available to some patients with advanced breast cancer on the NHS in England.
An immunotherapy drug will be made available on the NHS in England for certain people with lung cancer.
People with a certain type of lymphoma will now have access to a targeted cancer drug, called brentuximab vedotin, on the NHS in England.